Early transplantation of unrelated cord blood in a two-month-old infant with Wiskott-Aldrich syndrome

Pediatric Transplantation

Volumn 11, Issue 5, 2007, Pages 557-559

  Jaing, Tang Her ^a,b   Tsai, Bih Yu ^a   Chen, Shih Hsiang ^a   Lee, Wei I ^a   Chang, Kuei Wen ^a   Chu, Shih Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Unrelated cord blood transplantation; Wiskott Aldrich syndrome; Young infant

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE REDUCTION; FAMILY HISTORY; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; LABORATORY TEST; MALE; PEDIGREE; POLYMERASE CHAIN REACTION; RECTUM HEMORRHAGE; THROMBOCYTOPENIA; VIRAL CONTAMINATION; WISKOTT ALDRICH SYNDROME;

CORD BLOOD STEM CELL TRANSPLANTATION; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; TIME FACTORS; WISKOTT-ALDRICH SYNDROME;

EID: 34447300237     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00732.x     Document Type: Article

References (12)

1. Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP mutations. Blood 2004 : 103 : 456 464.
2. Robayashi R, Ariga T, Nonoyama S, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: An analysis of 57 patients in Japan. Br J Haematol 2006 : 135 : 362 366.
3. Slatter MA, Bhattachary A, Flood TJ, et al. Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr Blood Cancer 2006 : 47 : 332 334.
4. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994 : 125 : 876 885.
5. Dogu F, Kurtulus-Ulkuer M, Bilge Y, et al. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome. Pediatr Transplant 2006 : 10 : 395 399.
6. Puck JM, Candotti F. Focus on research: Lessons from the Wiskott-Aldrich Syndrome. N Engl J Med 2006 : 355 : 1759 1761.
7. Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 tandem meetings. Biol Blood Marrow Transplant 2001 : 7 : 473 485.
8. Pai SY, Demartis D, Forino C, et al. Stem cell transplantation for the Wiskott-Aldrich syndrome: A single-center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant 2006 : 38 : 671 679.
9. Langer T, Beck JD, Gravou-Apostulatou C, et al. Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity. Pediatr Transplant 2003 : 7 : 494 496.
10. Brunstein CG, Weisdorf DJ, Defor T, et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of anti-thymocyte globulin to a non-myeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006 : 108 : 2874 2880.
11. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Registry and the National Marrow Donor Program. Blood 2001 : 97 : 1598 1603.
12. Kaneko M, Tsutomu W, Hiroyoshi W, et al. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich Syndrome following recurrent cytomegalovirus disease. Int J Hematol 2003 : 78 : 457 460.